Home · Stock · IQV

IQV IQVIA Holdings Inc

Which ETFs hold IQV? IQVIA Holdings Inc is held by 2 funds tracked by ETFpeek.

Held by 2 funds todayData as of 31 Aug 2026
HealthcareDiagnostics & Research
$258.88
+30.6% 1y
$154.5052-week range$277.40
Market cap
$42.5B
P/E
32.2
3-month
+24.6%
CEO
Mr. Ari Bousbib
Revenue · last 4 qtrs (+8.7% YoY)

IQVIA Holdings Inc. provides clinical research services, commercial insights, and healthcare intelligence to the life sciences and healthcare industries in the Americas, Europe, Africa, and the Asia-Pacific. It operates through three segments: Technology & Analytics Solutions, Research & Development Solutions, and Contract Sales & Medical Solutions. The Technology & Analytics Solutions segment offers a range of cloud-based applications and associated implementation services; real world solutions that enable life sciences and provider customers to generate and disseminate evidence, which informs health care decision making and improves patients' outcomes; and strategic and implementation consulting services, such as advanced analytics and commercial processes outsourcing services. This segment also provides country level performance metrics related to sales of pharmaceutical products, prescribing trends, medical treatment, and promotional activity across various channels, including retail, hospital, and mail order; and measurement of sales or prescribing activity at the regional, zip code, and individual prescriber level. The Research & Development Solutions segment offers project management and clinical monitoring; clinical trial support; strategic planning and design services; and patient and site centric solutions, as well as central laboratory, genomic, bioanalytical, ADME, discovery, vaccine and biomarker laboratory services. The Contract Sales & Medical Solutions segment provides health care provider and patient engagement services, and scientific strategy and medical services. It serves pharmaceutical, biotechnology, device and diagnostic, and consumer health companies. The company has a strategic collaboration with Kexing Biopharm Co., Ltd. for biosimilar development. The company was formerly known as Quintiles IMS Holdings, Inc. and changed its name to IQVIA Holdings Inc. in November 2017. IQVIA Holdings Inc. is based in Durham, North Carolina.

Provider

Currently Held By

VANGUARD
VOO
Weight in fund0.07%
Shares held4,431,243
Market value$1.16B
View fund →
SMARTSHARES
USF
Smart US 500 ETF
via VOO
Weight in fund0.07%
Shares held—
Market value$825K NZD
View fund →
Not held by the selected provider.
last 90 days
No insider activity recorded in the last 90 days.
0 trades
DateFundDirectionShares Changed% Δ ETF i% Δ Position i
No trades recorded yet.
No trade history for SmartShares funds — their underlying ETFs are passive index trackers, so day-to-day rebalancing is minimal.

More stocks in these funds